Skip to main content

and
Your search also matched 63 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial

Include preview-only content
  1. Article

    Open Access

    Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study

    Metabolic syndrome (MetS) is associated with cardiovascular disease in the general population and is also a potential cardiovascular risk factor in survivors of haematopoietic cell transplantation (HCT). We re...

    D. M. Greenfield, N. Salooja, C. Peczynski, S. van der Werf in Bone Marrow Transplantation (2021)

  2. Article

    Open Access

    Alloreactivity: the Janus-face of hematopoietic stem cell transplantation

    Differences in major and minor histocompatibility antigens between donor and recipient trigger powerful graft-versus-host reactions after allogeneic hematopoietic stem cell transplantation (HSCT). The clinical...

    A Gratwohl, A Sureda, J Cornelissen, J Apperley, P Dreger, R Duarte in Leukemia (2017)

  3. Article

    Erratum: GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses

    Correction to: Bone Marrow Transplantation (2017) 52, 544–551; doi:10.1038/bmt.2016.305; published online 12 December 2016 Since the online publication of this article the authors realised there were errors in...

    L Sellner, M Brüggemann, M Schlitt, H Knecht, D Herrmann in Bone Marrow Transplantation (2017)

  4. Article

    Open Access

    Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

    A record number of 40 829 hematopoietic stem cell transplantation (HSCT) in 36 469 patients (15 765 allogeneic (43%), 20 704 autologous (57%)) were reported by 656 centers in 47 countries to the 2014 survey. T...

    J R Passweg, H Baldomero, P Bader, C Bonini, S Cesaro in Bone Marrow Transplantation (2016)

  5. Article

    Open Access

    Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

    A record number of 39 209 HSCT in 34 809 patients (14 950 allogeneic (43%) and 19 859 autologous (57%)) were reported by 658 centers in 48 countries to the 2013 survey. Trends include: more growth in allogenei...

    J R Passweg, H Baldomero, P Bader, C Bonini, S Cesaro in Bone Marrow Transplantation (2015)

  6. Article

    Open Access

    Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation

    In all, 661 of 680 centers in 48 countries reported 37 818 hematopoietic SCT (HSCT) in 33 678 patients (14 165 allogeneic (42%), 19 513 autologous (58%)) in the 2012 survey. Main indications were leukemias, 10...

    J R Passweg, H Baldomero, C Peters, H B Gaspar, S Cesaro in Bone Marrow Transplantation (2014)

  7. Article

    Erratum: Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

    Correction to: Bone Marrow Transplantation advance online publication, 29 July 2013; doi:10.1038/bmt.2013.107 Since the publication of this article the authors have noticed an error in Table 1 under the sectio...

    T Ruutu, A Gratwohl, T de Witte, B Afanasyev, J Apperley in Bone Marrow Transplantation (2014)

  8. Article

    Open Access

    Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit

    Respiratory syncytial virus (RSV) usually causes self-limiting upper respiratory tract infections, but can be associated with severe lower respiratory tract infection disease (LRTID) in infants and in patients...

    N Lehners, P Schnitzler, S Geis, J Puthenparambil, M A Benz in Bone Marrow Transplantation (2013)

  9. Article

    Open Access

    Hematopoietic SCT in Europe: data and trends in 2011

    In all, 651 from 680 centers in 48 countries reported 35 660 hematopoietic SCT (HSCT) in 32 075 patients (13 470 allogeneic (42%), 18 605 autologous (58%)) to the 2011 survey. Main indications were: leukemias;...

    J R Passweg, H Baldomero, M Bregni, S Cesaro, P Dreger in Bone Marrow Transplantation (2013)

  10. Article

    The prognostic impact of minimal residual disease assessment after stem cell transplantation for chronic lymphocytic leukemia: is achievement of molecular remission worthwhile?

    P Dreger, M Ritgen, S Böttcher, N Schmitz, M Kneba in Leukemia (2005)